<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" />
    <title>Elisence – Evidence Hub (Technical, Product &amp; Ministry Readiness)</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <meta name="description" content="Evidence hub for Elisence – technical evidence, product evidence and ministry compatibility for Qatar, GCC and global partners.">
    <!-- Elisa chat widget -->
    <script defer src="elisa-chat.js"></script>

    <style>
        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        body {
            min-height: 100vh;
            font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
            background: radial-gradient(circle at top, #04101f 0%, #02040a 45%, #000000 100%);
            color: #ffffff;
            overflow-x: hidden;
            line-height: 1.6;
        }

        /* نقطه و لوگوی بالا */
        .top-dot {
            position: fixed;
            left: 18px;
            top: 18px;
            width: 14px;
            height: 14px;
            border-radius: 50%;
            background: radial-gradient(circle, #34c8ff, #0065ff 65%, #000c28 100%);
            box-shadow: 0 0 18px rgba(0, 170, 255, 0.9);
            z-index: 20;
        }

        .top-dot-label {
            position: fixed;
            left: 40px;
            top: 16px;
            font-size: 14px;
            letter-spacing: 0.22em;
            text-transform: uppercase;
            color: #a9d4ff;
            z-index: 20;
        }

        /* منوی عمودی سمت راست – استایل یکسان با سایر صفحات اصلی */
        .side-nav {
            position: fixed;
            right: 32px;
            top: 50%;
            transform: translateY(-50%);
            display: flex;
            flex-direction: column;
            gap: 12px;
            z-index: 999;
        }

        .nav-btn {
            display: block;
            padding: 13px 38px;
            border-radius: 999px;
            text-decoration: none;
            font-size: 14px;
            letter-spacing: 0.14em;
            text-transform: uppercase;
            color: #e3f2ff;
            background: radial-gradient(circle at top, rgba(0, 130, 255, 0.45), rgba(0, 10, 35, 0.97));
            border: 1px solid rgba(90, 185, 255, 0.9);
            box-shadow:
                0 0 16px rgba(0, 130, 255, 0.95),
                0 0 34px rgba(0, 40, 120, 0.95);
            transition: transform 0.2s ease, box-shadow 0.2s ease, background 0.2s ease, padding 0.2s ease;
        }

        .nav-btn:hover {
            transform: translateX(-4px);
            padding-right: 44px;
            box-shadow:
                0 0 22px rgba(0, 190, 255, 1),
                0 0 46px rgba(0, 80, 200, 1);
            background: radial-gradient(circle at top, rgba(0, 170, 255, 0.7), rgba(0, 25, 80, 1));
        }

        .nav-btn:active {
            transform: translateX(-2px) scale(0.99);
        }

        /* وضعیت فعال برای Evidence */
        .nav-btn.evidence-active {
            background: radial-gradient(circle at top, rgba(56, 189, 248, 0.85), rgba(8, 47, 73, 0.98));
            border-color: rgba(125, 211, 252, 0.95);
            box-shadow:
                0 0 22px rgba(56, 189, 248, 1),
                0 0 50px rgba(37, 99, 235, 0.95);
        }

        /* محتوای اصلی صفحه */
        .page-shell {
            min-height: 100vh;
            display: flex;
            align-items: flex-start;
            justify-content: center;
            padding: 80px 40px 80px 40px;
        }

        .content-main {
            width: 100%;
            max-width: 1100px;
            margin-right: 190px;
        }

        h1 {
            font-size: 2rem;
            margin-bottom: 0.6rem;
            color: #38bdf8;
        }

        .lead {
            font-size: 1rem;
            color: #cbd5f5;
            margin-bottom: 1.2rem;
            max-width: 900px;
        }

        .tagline {
            font-size: 0.95rem;
            color: #e1eeff;
            margin-bottom: 1.8rem;
            max-width: 900px;
        }

        .pill-row {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            margin-bottom: 1.6rem;
        }

        .pill {
            padding: 6px 14px;
            border-radius: 999px;
            border: 1px solid rgba(125, 211, 252, 0.8);
            font-size: 0.8rem;
            letter-spacing: 0.12em;
            text-transform: uppercase;
            color: #e0f2fe;
            background: rgba(15, 23, 42, 0.9);
        }

        .card {
            background: rgba(15, 23, 42, 0.95);
            border-radius: 18px;
            border: 1px solid #1e293b;
            box-shadow:
                0 0 22px rgba(0, 140, 255, 0.9),
                0 0 40px rgba(0, 40, 120, 0.9);
            padding: 1.8rem 1.9rem;
            margin-bottom: 1.8rem;
        }

        .card h2 {
            margin-top: 0;
            margin-bottom: 0.8rem;
            font-size: 1.3rem;
            color: #7dd3fc;
        }

        .card p {
            margin: 0.4rem 0;
            font-size: 0.95rem;
            color: #e5f2ff;
        }

        .card ul {
            margin: 0.5rem 0 0.2rem 1.2rem;
            padding-left: 0.4rem;
        }

        .card li {
            margin-bottom: 0.35rem;
            font-size: 0.93rem;
            color: #dceafe;
        }

        .link-row {
            margin-top: 0.8rem;
        }

        .link-row a {
            display: inline-block;
            margin-right: 12px;
            margin-top: 6px;
            font-size: 0.9rem;
            color: #7dd3fc;
            text-decoration: none;
        }

        .link-row a:hover {
            text-decoration: underline;
        }

        @media (max-width: 900px) {
            .page-shell {
                padding: 80px 18px 100px 18px;
            }

            .content-main {
                margin-right: 0;
            }

            .side-nav {
                position: fixed;
                right: 50%;
                top: auto;
                bottom: 18px;
                transform: translateX(50%);
                flex-direction: row;
                flex-wrap: wrap;
                justify-content: center;
                gap: 8px;
            }

            .nav-btn {
                padding: 9px 20px;
                font-size: 11px;
                letter-spacing: 0.11em;
            }
        }
    </style>
</head>
<body>

    <div class="top-dot"></div>
    <div class="top-dot-label">ELISENCE</div>

    <!-- منوی عمودی سمت راست -->
    <nav class="side-nav">
        <a href="index.html"        class="nav-btn">Home</a>
        <a href="index.html#phases" class="nav-btn">Phases</a>
        <a href="governments.html"  class="nav-btn">Governments</a>
        <a href="evidence.html"     class="nav-btn evidence-active">Evidence</a>
        <a href="about.html"        class="nav-btn">About</a>
        <a href="story.html"        class="nav-btn">Story</a>
        <a href="video.html"        class="nav-btn">Videos</a>
        <a href="contact.html"      class="nav-btn">Contact</a>
        <a href="founder-saami.html" class="nav-btn">Founder</a>
        <a href="articles.html"     class="nav-btn">Articles</a>
    </nav>

    <div class="page-shell">
       <!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8" />
    <title>Elisence – Evidence Hub (Technical, Product &amp; Ministry Readiness)</title>
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <meta name="description" content="Evidence hub for Elisence – technical evidence, product evidence and ministry compatibility for Qatar, GCC and global partners.">
    <!-- Elisa chat widget -->
    <script defer src="elisa-chat.js"></script>

    <style>
        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }

        body {
            min-height: 100vh;
            font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
            background: radial-gradient(circle at top, #04101f 0%, #02040a 45%, #000000 100%);
            color: #ffffff;
            overflow-x: hidden;
            line-height: 1.6;
        }

        /* نقطه و لوگوی بالا */
        .top-dot {
            position: fixed;
            left: 18px;
            top: 18px;
            width: 14px;
            height: 14px;
            border-radius: 50%;
            background: radial-gradient(circle, #34c8ff, #0065ff 65%, #000c28 100%);
            box-shadow: 0 0 18px rgba(0, 170, 255, 0.9);
            z-index: 20;
        }

        .top-dot-label {
            position: fixed;
            left: 40px;
            top: 16px;
            font-size: 14px;
            letter-spacing: 0.22em;
            text-transform: uppercase;
            color: #a9d4ff;
            z-index: 20;
        }

        /* منوی عمودی سمت راست – استایل یکسان با سایر صفحات اصلی */
        .side-nav {
            position: fixed;
            right: 32px;
            top: 50%;
            transform: translateY(-50%);
            display: flex;
            flex-direction: column;
            gap: 12px;
            z-index: 999;
        }

        .nav-btn {
            display: block;
            padding: 13px 38px;
            border-radius: 999px;
            text-decoration: none;
            font-size: 14px;
            letter-spacing: 0.14em;
            text-transform: uppercase;
            color: #e3f2ff;
            background: radial-gradient(circle at top, rgba(0, 130, 255, 0.45), rgba(0, 10, 35, 0.97));
            border: 1px solid rgba(90, 185, 255, 0.9);
            box-shadow:
                0 0 16px rgba(0, 130, 255, 0.95),
                0 0 34px rgba(0, 40, 120, 0.95);
            transition: transform 0.2s ease, box-shadow 0.2s ease, background 0.2s ease, padding 0.2s ease;
        }

        .nav-btn:hover {
            transform: translateX(-4px);
            padding-right: 44px;
            box-shadow:
                0 0 22px rgba(0, 190, 255, 1),
                0 0 46px rgba(0, 80, 200, 1);
            background: radial-gradient(circle at top, rgba(0, 170, 255, 0.7), rgba(0, 25, 80, 1));
        }

        .nav-btn:active {
            transform: translateX(-2px) scale(0.99);
        }

        /* وضعیت فعال برای Evidence */
        .nav-btn.evidence-active {
            background: radial-gradient(circle at top, rgba(56, 189, 248, 0.85), rgba(8, 47, 73, 0.98));
            border-color: rgba(125, 211, 252, 0.95);
            box-shadow:
                0 0 22px rgba(56, 189, 248, 1),
                0 0 50px rgba(37, 99, 235, 0.95);
        }

        /* محتوای اصلی صفحه */
        .page-shell {
            min-height: 100vh;
            display: flex;
            align-items: flex-start;
            justify-content: center;
            padding: 80px 40px 80px 40px;
        }

        .content-main {
            width: 100%;
            max-width: 1100px;
            margin-right: 190px;
        }

        h1 {
            font-size: 2rem;
            margin-bottom: 0.6rem;
            color: #38bdf8;
        }

        .lead {
            font-size: 1rem;
            color: #cbd5f5;
            margin-bottom: 1.2rem;
            max-width: 900px;
        }

        .tagline {
            font-size: 0.95rem;
            color: #e1eeff;
            margin-bottom: 1.8rem;
            max-width: 900px;
        }

        .pill-row {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            margin-bottom: 1.6rem;
        }

        .pill {
            padding: 6px 14px;
            border-radius: 999px;
            border: 1px solid rgba(125, 211, 252, 0.8);
            font-size: 0.8rem;
            letter-spacing: 0.12em;
            text-transform: uppercase;
            color: #e0f2fe;
            background: rgba(15, 23, 42, 0.9);
        }

        .card {
            background: rgba(15, 23, 42, 0.95);
            border-radius: 18px;
            border: 1px solid #1e293b;
            box-shadow:
                0 0 22px rgba(0, 140, 255, 0.9),
                0 0 40px rgba(0, 40, 120, 0.9);
            padding: 1.8rem 1.9rem;
            margin-bottom: 1.8rem;
        }

        .card h2 {
            margin-top: 0;
            margin-bottom: 0.8rem;
            font-size: 1.3rem;
            color: #7dd3fc;
        }

        .card p {
            margin: 0.4rem 0;
            font-size: 0.95rem;
            color: #e5f2ff;
        }

        .card ul {
            margin: 0.5rem 0 0.2rem 1.2rem;
            padding-left: 0.4rem;
        }

        .card li {
            margin-bottom: 0.35rem;
            font-size: 0.93rem;
            color: #dceafe;
        }

        .link-row {
            margin-top: 0.8rem;
        }

        .link-row a {
            display: inline-block;
            margin-right: 12px;
            margin-top: 6px;
            font-size: 0.9rem;
            color: #7dd3fc;
            text-decoration: none;
        }

        .link-row a:hover {
            text-decoration: underline;
        }

        /* جدول وضعیت فازها */
        .status-table-wrapper {
            margin-top: 0.8rem;
            overflow-x: auto;
        }

        table.status-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 0.9rem;
        }

        table.status-table th,
        table.status-table td {
            border-bottom: 1px solid #1f2937;
            padding: 0.55rem 0.4rem;
            text-align: left;
        }

        table.status-table th {
            color: #93c5fd;
            font-weight: 600;
        }

        table.status-table tr:nth-child(even) {
            background: rgba(15, 23, 42, 0.7);
        }

        table.status-table tr.phase-highlight {
            background: rgba(8, 47, 73, 0.85);
        }

        table.status-table tr.phase-highlight td {
            font-weight: 600;
            color: #e0f2fe;
        }

        .badge {
            display: inline-block;
            padding: 3px 10px;
            border-radius: 999px;
            font-size: 0.75rem;
            letter-spacing: 0.08em;
            text-transform: uppercase;
        }

        .badge-success {
            background: rgba(22, 163, 74, 0.18);
            border: 1px solid rgba(74, 222, 128, 0.7);
            color: #bbf7d0;
        }

        .badge-pending {
            background: rgba(202, 138, 4, 0.12);
            border: 1px solid rgba(251, 191, 36, 0.7);
            color: #facc15;
        }

        @media (max-width: 900px) {
            .page-shell {
                padding: 80px 18px 100px 18px;
            }

            .content-main {
                margin-right: 0;
            }

            .side-nav {
                position: fixed;
                right: 50%;
                top: auto;
                bottom: 18px;
                transform: translateX(50%);
                flex-direction: row;
                flex-wrap: wrap;
                justify-content: center;
                gap: 8px;
            }

            .nav-btn {
                padding: 9px 20px;
                font-size: 11px;
                letter-spacing: 0.11em;
            }
        }
    </style>
</head>
<body>

    <div class="top-dot"></div>
    <div class="top-dot-label">ELISENCE</div>

    <!-- منوی عمودی سمت راست -->
    <nav class="side-nav">
        <a href="index.html"        class="nav-btn">Home</a>
        <a href="index.html#phases" class="nav-btn">Phases</a>
        <a href="governments.html"  class="nav-btn">Governments</a>
        <a href="evidence.html"     class="nav-btn evidence-active">Evidence</a>
        <a href="about.html"        class="nav-btn">About</a>
        <a href="story.html"        class="nav-btn">Story</a>
        <a href="video.html"        class="nav-btn">Videos</a>
        <a href="contact.html"      class="nav-btn">Contact</a>
        <a href="founder-saami.html" class="nav-btn">Founder</a>
        <a href="articles.html"     class="nav-btn">Articles</a>
    </nav>

    <div class="page-shell">
        <main class="content-main">
            <h1>Evidence Hub – Technical, Product &amp; Ministry Readiness</h1>

            <p class="lead">
                This page is the central entry point for the full <strong>Evidence Pack</strong> of Elisence:
                technical engines and tests (B1), product-level evidence (B2), and ministry compatibility
                (B3) for Qatar, GCC and global partners.
            </p>

            <p class="tagline">
                Instead of publishing every internal file publicly, we keep the website clean and use this hub
                to show what is already real today – and how deeper PDF packs can be shared privately with
                QDB, QFC, QSTP or ministries when needed.
            </p>

            <div class="pill-row">
                <span class="pill">Technical Engines</span>
                <span class="pill">Real Product Demos</span>
                <span class="pill">Ministry Compatibility</span>
                <span class="pill">Non-diagnostic</span>
                <span class="pill">GCC &amp; Multi-language</span>
                <span class="pill">Zero-Trust &amp; WORM</span>
            </div>

            <!-- SUMMARY OF B1/B2/B3 ARCHITECTURE -->
            <section class="card">
                <h2>Evidence Architecture – B1, B2 and B3</h2>
                <p>
                    The Elisence Evidence Pack is organised in three connected layers, so that ministries,
                    regulators and investors can see the whole picture quickly and then dive deeper where needed:
                </p>
                <ul>
                    <li>
                        <strong>B1 – Technical Evidence (Backend):</strong>
                        engines, files, feature flags, WORM logs and pytest suites for each phase.
                    </li>
                    <li>
                        <strong>B2 – Product Evidence:</strong>
                        what real citizens, clinicians, families and ministries see – website, videos,
                        UIs and storyboards.
                    </li>
                    <li>
                        <strong>B3 – Ministry Compatibility &amp; Governance:</strong>
                        non-diagnostic posture, data-sovereignty, Zero-Trust, and alignment with
                        Qatar / GCC expectations and global digital-health standards.
                    </li>
                </ul>
                <p>
                    The sections below follow exactly this structure and can be extended as more phases
                    reach SEAL status.
                </p>
            </section>

            <!-- PHASE STATUS MATRIX – TEMPLATE برای همه فازها -->
            <section class="card">
                <h2>Phase Evidence Status – 17-Phase Roadmap</h2>
                <p>
                    Elisence is built as a 17-phase platform. Not every phase is sealed yet; this table shows the
                    current high-level technical and evidence status. As you add more phases, you can simply add
                    new rows to this matrix.
                </p>

                <div class="status-table-wrapper">
                    <table class="status-table">
                        <thead>
                            <tr>
                                <th>Phase</th>
                                <th>Scope</th>
                                <th>Status</th>
                                <th>Evidence</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Phase 1</td>
                                <td>GLP-1 &amp; Metabolic Intelligence Core</td>
                                <td><span class="badge badge-pending">Engine built</span></td>
                                <td>Core engine and tests in progress; internal technical pack available on request.</td>
                            </tr>
                            <tr>
                                <td>Phase 3</td>
                                <td>Care Engine (Elderly / Safety)</td>
                                <td><span class="badge badge-pending">Running backend</span></td>
                                <td>UI + APIs live; WORM logs and test runs captured as part of B1 technical pack.</td>
                            </tr>
                            <tr>
                               <td>Phase 7</td>
                                <tr>
                                 <tr class="phase-highlight">
                                        <td>Phase 7</td>
                                        <td>Women+ Health &amp; Safety Engine</td>
                                        <td><span class="badge badge-success">SEAL: FINAL – 423/423 TESTS PASSED</span></td>
                                        <td>
                                            Public SEAL repository, SHA-256 anchored manifest, WORM audit declaration and full
                                            BBVP-grade governance evidence (see section below).
                                        </td>
                                    </tr>
                                                                        </td>
                                </tr>
                                    
                                    <tr>
                                    <td>Phase 8</td>
                                    <td>Advanced Haematology &amp; Emergencies (AHE)</td>
                                    <td><span class="badge badge-pending">Core engine live</span></td>
                                    <td>Blood engine, WORM audit v2 and risk-engine tests in green; scaling and dashboards in progress.</td>
                                    </tr>
                                    <tr class="phase-highlight">
                                    <td>Phase 9</td>
                                    <td>Diabetes Engine</td>
                                    <td><span class="badge badge-success">SEAL: Final – 95/95 tests passed</span></td>
                                    <td>Public SEAL repository, SHA-256 manifest and full BBVP-grade evidence (see section below).</td>
                            </tr>
                            <tr>
                                <td>Phase 10</td>
                                <td>Children &amp; Family – ELIS Messaging</td>
                                <td><span class="badge badge-pending">Core complete</span></td>
                                <td>Secure messaging, media and audit engines running; evidence pack in preparation.</td>
                            </tr>
                            <tr>
                                <td>Other Phases</td>
                                <td>Voice, Mental Health, Nutrition, National Identity and more</td>
                                <td><span class="badge badge-pending">In progress</span></td>
                                <td>Specifications and prototypes active; evidence rows will be added here as each phase is sealed.</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <p>
                    This matrix is deliberately simple and readable for ministries and investors. Each row
                    can link down to a detailed “Phase Evidence Card” as engines move from prototype to SEAL.
                </p>
            </section>

            <!-- FEATURED PHASE CARD – PHASE 9 SEAL -->
            <section class="card">
                <h2>Phase 9 – Diabetes Engine (SEAL Package)</h2>
                <p>
                    Phase 9 is the first Elisence engine to reach full <strong>SEAL</strong> status. It converts
                    real-world diabetes and metabolic data into structured, non-diagnostic intelligence for
                    families, clinicians and ministries – with a complete technical and regulatory evidence trail.
                </p>
                <ul>
                    <li>Core diabetes engine and context logic in <code>main_phase9_base.py</code>.</li>
                    <li>Non-medical policy bundle in five languages (EN / FA / AR / TR / RO).</li>
                    <li>Zero-Trust feature-flag matrix with OFF=503 and ON=200 semantics.</li>
                    <li>WORM audit logging and seal manifest for evidence-grade traceability.</li>
                    <li>Full pytest suite (95 tests) with OFF/ON, safety-gate and canonical-tree checks.</li>
                </ul>
                <p>
                    The complete Phase 9 package is published as a dedicated public repository, so that ministries,
                    technical reviewers and investors can see exactly what is built and how it is governed.
                </p>

               <div class="link-row">
    <a href="https://github.com/sami1856/Elisence_Phase9_Diabetes_SEAL"
       target="_blank" rel="noopener">
        Open Phase 9 SEAL repository →
    </a>

    <a href="https://github.com/sami1856/Elisence_Phase9_Diabetes_SEAL/blob/master/REPORT/PHASE9_FINAL_MANIFEST_v1.txt"
       target="_blank" rel="noopener">
        View PHASE9_FINAL_MANIFEST_v1.txt →
    </a>

    <a href="https://github.com/sami1856/Elisence_Phase9_Diabetes_SEAL/blob/master/REPORT/PHASE9_SHA256.txt"
       target="_blank" rel="noopener">
        View PHASE9_SHA256.txt →
    </a>

    <!-- لینک جدید داخل خود وبسایت -->
    <a href="phase9-evidence-card.html">
        Open Phase 9 Evidence Card →
    </a>
</div>
                <p>
                    For QDB, QFC, QSTP or ministries, a deeper Phase 9 Evidence Pack (with diagrams, WORM excerpts,
                    test reports and legal notes) can be shared as a PDF bundle, built directly from this SEAL repo.
                </p>
            </section>
            <!-- FEATURED PHASE CARD – PHASE 7 SEAL -->
<section class="card">
    <h2>Phase 7 – Women+ Health & Safety Engine (SEAL Package)</h2>
    <p>
        Phase 7 is the first large-scale behavioural and safety intelligence engine inside Elisence.
        It structures women’s health, hormonal, reproductive and lifecycle data into safe,
        non-diagnostic intelligence for citizens, clinicians and ministries — under a strict
        BBVP-governed evidence model.
    </p>

    <ul>
        <li>Core Women+ engine logic in <code>main_phase7_base.py</code>.</li>
        <li>Deterministic safety & risk-tag inference layer (rule-based, explainable).</li>
        <li>Non-diagnostic boundary enforcement (no prescriptions, no diagnoses, no dosage advice).</li>
        <li>Zero-Trust feature-flag matrix with OFF=503 and ON=200 semantics.</li>
        <li>WORM v2 audit logging (append-only JSONL) for governance-grade traceability.</li>
        <li>Full pytest suite (423 tests) covering OFF/ON, safety gates, trace IDs and regression matrix.</li>
        <li>Five-language backbone (EN / FA / AR / TR / RO) with RTL-ready support.</li>
        <li>Clinical boundary lock aligned with NHS-style governance logic and GCC PDPL expectations.</li>
    </ul>

    <p>
        The complete Phase 7 Women+ module is published as dedicated public SEAL repositories,
        allowing ministries, regulators, technical reviewers and investors to inspect both
        the engine and its formal Evidence Pack.
    </p>

    <div class="link-row">

        <a href="https://github.com/sami1856/Elisence_Phase7_WomenPlus_SEAL"
           target="_blank" rel="noopener">
            Open Phase 7 SEAL repository →
        </a>

        <a href="https://github.com/sami1856/Elisence_Phase7_WomenPlus_EVIDENCE"
           target="_blank" rel="noopener">
            Open Phase 7 Evidence Pack repository →
        </a>

        <a href="https://github.com/sami1856/Elisence_Phase7_WomenPlus_EVIDENCE/releases/tag/v1.0"
           target="_blank" rel="noopener">
            View Phase 7 SEAL Release v1.0 →
        </a>

        <a href="https://github.com/sami1856/Elisence_Phase7_WomenPlus_EVIDENCE/blob/master/MASTER_MANIFEST_v1.txt"
           target="_blank" rel="noopener">
            View MASTER_MANIFEST_v1.txt →
        </a>

        <a href="https://github.com/sami1856/Elisence_Phase7_WomenPlus_EVIDENCE/blob/master/SHA256_SUMMARY.txt"
           target="_blank" rel="noopener">
            View SHA256 Summary →
        </a>

        <!-- لینک داخلی سایت -->
        <a href="phase7-evidence-card.html">
            Open Phase 7 Evidence Card →
        </a>

    </div>

    <p>
        For QDB, QFC, QSTP or ministries, a deeper Phase 7 Evidence Pack
        (including regression matrices, WORM excerpts, trace validation reports,
        policy bundles and governance notes) can be delivered as a structured PDF bundle,
        generated directly from the SEAL repositories.
    </p>
</section>
            <!-- B1 – TECHNICAL EVIDENCE PACK -->
            <section class="card">
                <h2>B1 — Technical Evidence Pack (Backend)</h2>
                <p>
                    The Technical Evidence Pack shows what is actually built inside Elisence:
                    engines, files, safety gates and tests, <strong>phase by phase</strong>.
                </p>
                <ul>
                    <li>Phase-by-phase technical status across all 17 phases (what is built, which files and artefacts exist).</li>
                    <li>Safety layers including WORM audit logs, provenance exports and health / integrity checks.</li>
                    <li>
                        Screenshots and extracts from:
                        <ul>
                            <li>Real UI in running backends,</li>
                            <li>WORM JSONL logs,</li>
                            <li>pytest results (passed / skipped focus),</li>
                            <li>FastAPI <code>/docs</code> and <code>/openapi.json</code> views.</li>
                        </ul>
                    </li>
                    <li>
                        For QDB, QFC, QSTP or ministries, these items can be bundled into a
                        <strong>PDF Technical Evidence Pack</strong> for internal/legal review.
                    </li>
                </ul>
                <p>
                    On the website, the live technical status is summarised on a dedicated page.
                    Deeper logs and screenshots stay private and are shared only on request.
                </p>
                <div class="link-row">
                    <a href="technical-evidence.html">Open Technical Evidence →</a>
                </div>
            </section>

            <!-- B2 – PRODUCT EVIDENCE PACK -->
            <section class="card">
                <h2>B2 — Product Evidence Pack</h2>
                <p>
                    The Product Evidence Pack focuses on how Elisence looks and behaves for real people:
                    citizens, clinicians, ministries and families – especially in the key phases already built.
                </p>
                <ul>
                    <li>
                        <strong>Links to YouTube product videos</strong> for major phases
                        (including Diabetes – Phase 9, Women+ – Phase 7, Family – Phase 15,
                        Global Nutrition – Phase 16, and others) via the public Videos page.
                    </li>
                    <li>
                        <strong>Web pages as live evidence:</strong> Home, Phases overview,
                        Governments &amp; Qatar, Story, Founder and Articles – all part of the
                        working product surface, not just design mockups.
                    </li>
                    <li>
                        <strong>UI mockups</strong> for ministry dashboards, clinician panels and
                        family / citizen apps, prepared for review sessions (kept private or under NDA).
                    </li>
                    <li>
                        <strong>Storyboards</strong> for key phases (for example Phases 9, 7, 15, 16)
                        showing scene-by-scene flows of how a citizen, a clinician and a ministry
                        actually interact with Elisence.
                    </li>
                </ul>
                <p>
                    Only the live website and videos are public. Full product packs
                    (screenshots, UI mockups, storyboard PDFs) are shared privately with ministries
                    and investors as part of the Evidence Pack.
                </p>
                <div class="link-row">
                    <a href="product-evidence.html">Open Product Evidence →</a>
                    <a href="video.html">Go to Videos page →</a>
                </div>
            </section>

            <!-- DOWNLOADS – PDFs / WHITEPAPERS -->
            <section class="card">
                <h2>Downloads — PDFs &amp; Whitepapers</h2>
                <p>
                    Some parts of the Evidence Pack must be available as downloadable PDFs:
                    short summaries for Qatar, technical overviews and executive briefs that
                    can be attached to applications or shared internally.
                </p>
                <ul>
                    <li>Qatar Summary / 1-pager and related Qatar PDFs.</li>
                    <li>High-level technical and product overviews for Elisence.</li>
                    <li>Selected extracts from technical and product evidence for internal archives.</li>
                </ul>
                <p>
                    These documents are maintained on a dedicated downloads page and can be extended
                    as more phases reach fully documented status.
                </p>
                <div class="link-row">
                    <a href="download.html">Go to Downloads →</a>
                </div>
            </section>

            <!-- B3 – MINISTRY COMPATIBILITY -->
            <section class="card">
                <h2>B3 — Ministry Compatibility Evidence (Qatar &amp; GCC Ready)</h2>
                <p>
                    Elisence is designed from day one as a <strong>national-grade digital health platform</strong>,
                    not just a consumer app. This section summarises how the platform fits the expectations of
                    ministries of health, public hospitals, QDB/QFC/QSTP evaluators and GCC regulators.
                </p>

                <ul>
                    <li>
                        <strong>Non-diagnostic, non-prescriptive posture:</strong>
                        Elisence does <em>not</em> give diagnoses, does not replace doctors, and does not
                        issue prescriptions. It structures data, highlights risk, explains patterns and
                        routes citizens to appropriate care.
                    </li>
                    <li>
                        <strong>Built for ministries, hospitals and schools:</strong>
                        The platform is designed so that a Ministry of Health, public hospital network,
                        school system or national programme can safely deploy it as part of their own
                        digital health ecosystem — not as a standalone foreign app.
                    </li>
                    <li>
                        <strong>Data-sovereignty &amp; hosting:</strong>
                        Architecture is compatible with Qatar and wider GCC data-sovereignty expectations:
                        data can be hosted inside the country or approved GCC regions, with clear separation
                        between citizen data, analytics and research exports.
                    </li>
                    <li>
                        <strong>Zero-Trust, consent-first, privacy-by-design:</strong>
                        All sensitive actions use strict headers, passports and role-based access.
                        Every module follows Zero-Trust principles, with explicit consent, least-privilege
                        access and full audit trails (including WORM logs).
                    </li>
                    <li>
                        <strong>Global regulatory alignment (design level):</strong>
                        The governance model and evidence pack are aligned with the logic of
                        <em>NHS DCB0129/0160, EU MDR/MDCG, US FDA CDS</em> and <em>GCC data-protection / PDPL</em>
                        frameworks — always within a non-diagnostic decision-support boundary.
                    </li>
                    <li>
                        <strong>Automatic country-aware behaviour:</strong>
                        Elisence can recognise the user’s country/region and route them to the correct
                        safety rules, disclaimers and policy mappings for that jurisdiction (for example,
                        Qatar vs. UK vs. EU), while keeping one shared technical core.
                    </li>
                    <li>
                        <strong>Five-language backbone:</strong>
                        Core content and engines are designed around a 5-language baseline —
                        <strong>English, Farsi, Arabic, Turkish, Romanian</strong> — suitable for GCC, diaspora
                        communities and European partners, with RTL support for Arabic and Farsi.
                    </li>
                    <li>
                        <strong>BBVP standard (Build-Back-Verify-Prove):</strong>
                        Every phase follows an internal governance standard:
                        engines are built, then verified with tests and WORM logs, and finally
                        proven with manifests and SHA-256 evidence packs before being declared “Done”.
                    </li>
                </ul>

                <p>
                    For QDB, QFC, QSTP and ministries, this means Elisence is already operating as a
                    <strong>national digital health infrastructure layer</strong>, not just a prototype.
                </p>

                <p style="margin-top:0.9rem; font-weight:600;">
                    Official sector positioning for Qatar &amp; GCC:
                </p>
                <ul>
                    <li>HealthTech</li>
                    <li>Digital Health</li>
                    <li>AI &amp; Data Intelligence</li>
                    <li>Education / Behaviour Change (EdTech)</li>
                    <li>National Digital Platforms</li>
                </ul>

                <p style="margin-top:0.8rem;">
                    A dedicated <strong>Ministry Compatibility Pack (B3)</strong> can be shared privately
                    with Qatar or GCC authorities on request, including policy mappings, data-flow diagrams,
                    safety boundaries and governance documentation.
                </p>
            </section>

            <!-- QATAR EXPORT KIT -->
            <section class="card">
                <h2>Qatar Export Kit – How This Evidence Is Used</h2>
                <p>
                    In the A→Z roadmap for Qatar, this Evidence Hub feeds directly into the
                    <strong>Final Qatar Preparation Pack (Export Kit)</strong> that can be
                    submitted to QDB, QFC, QSTP or similar programmes.
                </p>
                <ul>
                    <li>Qatar 1-pager and “Why Qatar?” page.</li>
                    <li>Qatar company registration summary (QFC / QDB / QSTP path).</li>
                    <li>Full Evidence Pack (B1 technical + B2 product + B3 ministry compatibility).</li>
                    <li>Live website links and YouTube product videos.</li>
                    <li>Contact details and executive summary PDF.</li>
                    <li>
                        Two Qatar Pitch Decks (ministry version + investor version) prepared
                        from the same evidence base.
                    </li>
                </ul>
                <p>
                    Once sections A–E of the roadmap are complete, this export kit can be
                    assembled quickly from the verified website, engines and PDFs described
                    on this page.
                </p>
            </section>
        </main>
    </div>

    <!-- ریشهٔ ویجت Elisa -->
    <div id="elisa-chat-root"></div>
</body>
</html>
        </main>
    </div>

    <!-- ریشهٔ ویجت Elisa -->
    <div id="elisa-chat-root"></div>
</body>
</html>
